These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1673471)

  • 21. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of adrenergic beta-receptor blocking drugs on brain catecholamine concentrations in spontaneously hypertensive rats (SHR) (author's transl)].
    Inokuchi K
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):515-23. PubMed ID: 6110623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers and sleep: a controlled trial.
    Betts TA; Alford C
    Eur J Clin Pharmacol; 1985; 28 Suppl():65-8. PubMed ID: 2865152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents.
    Monti JM
    Life Sci; 1987 Oct; 41(17):1979-88. PubMed ID: 2890073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of kitchen salt and beta sympatholytics on the course of blood pressure in the hereditary, spontaneously hypertensive rat (SH rats, Münster strain)].
    Samizadeh A; Losse H; Wessels F
    Med Welt; 1977 Dec; 28(50):2050-5. PubMed ID: 23481
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of several beta-blocking agents on the development of hypertension in spontaneously hypertensive rats.
    Takeda K; Nakagawa Y; Hashimoto T; Sakurai H; Imai S
    Jpn J Pharmacol; 1979 Apr; 29(2):171-8. PubMed ID: 43908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties.
    Kostis JB; Rosen RC
    Circulation; 1987 Jan; 75(1):204-12. PubMed ID: 2878741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism.
    Sybertz EJ; Watkins RW
    Am J Cardiol; 1989 Jun; 63(19):3I-6I. PubMed ID: 2567112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute and chronic treatments with atenolol and propranolol on cardiovascular responses to handling stress in spontaneously hypertensive rats.
    Kudo Y; Sokabe H; Kawashima K
    J Pharmacobiodyn; 1983 Oct; 6(10):729-36. PubMed ID: 6141234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygraphic sleep studies in rats and humans: their use in psychopharmacological research.
    Loew DM; Spiegel R
    Arzneimittelforschung; 1976; 26(6):1032-5. PubMed ID: 989373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrandrine, an antihypertensive alkaloid, improves the sleep state of spontaneously hypertensive rats (SHRs).
    Zhang J; Yu B; Zhang XQ; Sheng ZF; Li SJ; Wang ZJ; Cui XY; Cui SY; Zhang YH
    J Ethnopharmacol; 2014; 151(1):729-32. PubMed ID: 24269338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the anti-hypertensive response to beta-adrenoceptor blocking drugs in intact and adrenal-demedullated spontaneously hypertensive rats.
    Buckingham RE; Hamilton TC
    Br J Pharmacol; 1980 Apr; 68(4):667-76. PubMed ID: 6103721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. REM sleep inhibition by desipramine: evidence for an alpha-1 adrenergic mechanism.
    Ross RJ; Gresch PJ; Ball WA; Sanford LD; Morrison AR
    Brain Res; 1995 Dec; 701(1-2):129-34. PubMed ID: 8925274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
    Kubota N; Kishi K; Sokabe H; Kawashima K; Ishii Y; Kawase S
    J Pharmacobiodyn; 1985 Feb; 8(2):134-41. PubMed ID: 2861268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quipazine has a biphasic effect on slow wave sleep and reduces REM sleep rebound in REM sleep deprived rats.
    Zak R; Radulovacki M
    Brain Res Bull; 1982 Mar; 8(3):329-31. PubMed ID: 7093740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological characteristics of the long-acting beta-blocker "bopindolol"].
    Nagatomo T; Hosohata Y; Ohnuki T; Suzuki J
    Nihon Yakurigaku Zasshi; 1997 Jan; 109(1):1-12. PubMed ID: 9067994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
    Kishi K; Kawashima K; Sokabe H; Saito K
    J Pharmacobiodyn; 1985 Jan; 8(1):50-5. PubMed ID: 2409263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of adrenergic blockers on the dog's sleep-wake pattern.
    Gordon CR; Lavie P
    Physiol Behav; 1984 Mar; 32(3):345-50. PubMed ID: 6463122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of melatonin involvement in pindolol-induced suppression of REM sleep.
    Monti JM; Jantos H; Monti D
    J Neural Transm (Vienna); 2001; 108(1):1-9. PubMed ID: 11261740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat.
    Monti JM; D'Angelo L; Jantos H; Barbeito L; Abó V
    Sleep; 1988 Aug; 11(4):370-7. PubMed ID: 2849796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.